WallStSmart

Lineage, Inc. Common Stock (LINE)vsTerreno Realty Corporation (TRNO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 1024% more annual revenue ($5.36B vs $476.38M). TRNO leads profitability with a 84.6% profit margin vs -1.9%. TRNO earns a higher WallStSmart Score of 72/100 (B).

LINE

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 5.0Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

TRNO

Strong Buy

72

out of 100

Grade: B

Growth: 9.3Profit: 7.5Value: 7.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

TRNOUndervalued (+64.2%)

Margin of Safety

+64.2%

Fair Value

$182.99

Current Price

$61.66

$121.33 discount

UndervaluedFair: $182.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

TRNO6 strengths · Avg: 9.3/10
Profit MarginProfitability
84.6%10/10

Keeps 85 of every $100 in revenue as profit

Operating MarginProfitability
42.0%10/10

Strong operational efficiency at 42.0%

Revenue GrowthGrowth
32.6%10/10

Revenue surging 32.6% year-over-year

EPS GrowthGrowth
99.6%10/10

Earnings expanding 99.6% YoY

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Revenue GrowthGrowth
-0.2%2/10

Revenue declined 0.2%

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

TRNO1 concerns · Avg: 2.0/10
PEG RatioValuation
7.702/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : TRNO

The strongest argument for TRNO centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 84.6% and operating margin at 42.0%. Revenue growth of 32.6% demonstrates continued momentum.

Bear Case : LINE

The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.

Bear Case : TRNO

The primary concerns for TRNO are PEG Ratio.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while TRNO is a growth play — different risk/reward profiles.

TRNO is growing revenue faster at 32.6% — sustainability is the question.

LINE generates stronger free cash flow (78M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TRNO scores higher overall (72/100 vs 36/100), backed by strong 84.6% margins and 32.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company at the forefront of regenerative medicine, specializing in the development of advanced cell therapy solutions aimed at treating severe diseases such as eye disorders, spinal cord injuries, and cancer. Leveraging proprietary technologies and a strong commitment to strategic partnerships, the company is dedicated to revolutionizing patient care with its novel therapeutic approaches. As Lineage continues to enhance its diverse product pipeline and accelerate clinical research initiatives, it represents a compelling opportunity for institutional investors looking to support transformative advancements in healthcare.

Visit Website →

Terreno Realty Corporation

REAL ESTATE · REIT - INDUSTRIAL · USA

Terreno Realty Corporation and together with its subsidiaries, the?

Want to dig deeper into these stocks?